Halozyme Therapeutics Inc (HALO)

Operating profit margin

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Operating income (ttm) US$ in thousands 551,475 477,009 402,091 379,314 337,574 311,048 306,061 245,663 267,531 249,556 241,850 300,837 275,902 296,992 261,705 198,213 144,255 34,569 -30,267 -73,799
Revenue (ttm) US$ in thousands 1,015,324 947,355 873,304 862,989 829,253 780,710 773,653 704,980 660,116 580,623 487,477 471,567 443,310 463,010 412,496 331,262 267,594 199,556 180,470 164,397
Operating profit margin 54.32% 50.35% 46.04% 43.95% 40.71% 39.84% 39.56% 34.85% 40.53% 42.98% 49.61% 63.80% 62.24% 64.14% 63.44% 59.84% 53.91% 17.32% -16.77% -44.89%

December 31, 2024 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $551,475K ÷ $1,015,324K
= 54.32%

Halozyme Therapeutics Inc's operating profit margin has displayed a mix of negative and positive trends over the analyzed period. Starting at a low of -44.89% in March 2020, the operating profit margin improved consistently, turning positive by September 2020 at 17.32%, and increasing significantly to 53.91% by December 2020. The company maintained a strong performance in the following quarters, reaching peak levels of 64.14% in September 2021.

However, from December 2021 to March 2022, there was a slight decline in the operating profit margin, which rebounded in June 2022 to 49.61%. Subsequently, a decreasing trend was observed, with the operating profit margin falling to 40.53% by December 2022.

In the following quarters, there was some fluctuation, but the operating profit margin generally improved, reaching 54.32% by December 2024. This indicates that the company has managed to maintain a generally healthy level of operating profitability, with some fluctuations in between. It is important for stakeholders to monitor these trends closely to assess the company's ability to generate profits from its core operations.